German licensed pharmaceutical distributor seeks outright divestiture for €299,000 OBO
An opportunity to acquire a fully licensed German pharmaceutical distributor purpose-built for the medical cannabis sector. The company operates under a lean, light-touch model leveraging outsourced logistics, compliance, and quality management partners, providing an efficient and scalable foundation for rapid market entry
Listing ID:
14916332561
Licence(s) Held:
Distribution (GDP) Licence and Narcotic Licence
Seeking outright divestiture of the licences for €299,000 o.b.o
Listing Details:
Fully licensed German medical cannabis wholesaler authorized to register, distribute, and sell medical cannabis products
Clean corporate structure, pre-revenue, no debt, and is currently fully licensed
Contracts in place with a licensed warehouse and logistics company for storage and distribution
Appointed Responsible Person for releasing narcotic and medical cannabis products, willing to stay on
Obtaining these licences typically requires 12–18 months, providing an immediate time-to-market advantage for an acquirer
Ideal for international producers, distributors, or investors seeking a compliant, plug-and-play platform to establish operations in Germany or the broader EU market
14916332561
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
36324927098
Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner
Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential
29345918591
State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub
Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.